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Pyrimidine has gained considerable attention because of its diversity in biological activity, such as anticarcinogenic and analgesic properties (Ashok et al., 2007) . Thiazoles and their derivatives are also found to be associated with various biological activities such as antibacterial, antifungal and anti-inflammatory properties (Jang et al., 2011) . Furthermore, the pyrimidines and thiazoles rings are found in the skeleton of many compounds with potent biological activity (Al-Rashood et al.,2010; Wichmann, et al., 1999) . Since the two heterocyclic moieties constitute two active pharmacophores that are highly active against inflammation and pain, combining the two is expected to have a synergistic effect in dealing with diseases.
In this paper, we report the molecular and crystal structure of (Z)-ethyl 2-(2,4-dimethylbenzylidene)-7-methyl-3-oxo-5-phenyl-3,5-dihydro-2H-thiazolo [3,2-a]pyrimidine-6-carboxylate (I). The molecule (I), consists of one thiazole ring and two benzene rings. The fused pyrimidine ring has usual geometry as observed in other fused pyrimidine compounds (Kulakov, et al., 2009; Zhao, et al., 2011) . The thiazole ring makes dihedral angles of 84.91 (11) and 11.58 (10)° with the benzene rings C7-C12 and C18-C23, respectively. The pyrimidine ring adopts a flattened boat conformation. The C2-C17 double bond exists in the Z configuration. The molecular structure of (I) is illustrated in Fig. 1 .
Experimental
In a one pot Biginelli reaction, a mixture of 5 mmol of benzaldehyde, 6 mmol ethyl acetoacetate, 7.5 mmol thiourea and 10 ml of EtOH was stirred at 50°C in presence of sulfamic acid catalyst for 3 h to obtain 6-methyl-4-phenyl-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate. Then the product (2 mmol) was reacted with ethyl chloroacetate (2 mmol) in the presence of pyridine for 4 h; and 2,4-dimethylbenzaldehyde (2 mmol) and piperidine were added, and the mixture refluxed for 4 h until the TLC assay indicated that the reaction was completed. The reaction mixture was cooled and filtered to give crude product. The solid was collected and crystallized from acetic acid to obtain the final product. Single crystals of the title compound were grown in a CH 2 Cl 2/ CH 3 OH mixture (2:1 v/v) by slow evaporation.
Refinement
The H atoms were positioned geometrically (C-H = 0.93 and 0.96 Å) and refined as riding with Uiso(H) = 1.2Ueq(C) or 1.5Ueq(methyl C).
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